Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Diana R. Andersen"'
Autor:
Sune Boris Nygård, Sönke Detlefsen, Diana R. Andersen, Per Pfeiffer, Camilla Qvortrup, Signe Lykke Nielsen, Line Schmidt Tarpgaard, Nils Brünner, Jan Stenvang, Niels Frank Jensen
Publikováno v:
BMC Cancer
Tarpgaard, L S, Qvortrup, C, Nygård, S B, Nielsen, S L, Andersen, D R, Jensen, N F, Stenvang, J, Detlefsen, S, Brünner, N & Pfeiffer, P 2016, ' A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification ', BMC Cancer, vol. 16, 91 . https://doi.org/10.1186/s12885-016-2124-5
Tarpgaard, L S, Qvortrup, C, Nygård, S B, Nielsen, S L, Andersen, D R, Jensen, N F, Stenvang, J, Detlefsen, S, Brünner, N & Pfeiffer, P 2016, ' A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification ', B M C Cancer, vol. 16, 91 . https://doi.org/10.1186/s12885-016-2124-5
Tarpgaard, L S, Qvortrup, C, Nygård, S B, Nielsen, S L, Andersen, D R, Jensen, N F, Stenvang, J, Detlefsen, S, Brünner, N & Pfeiffer, P 2016, ' A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification ', BMC Cancer, vol. 16, 91 . https://doi.org/10.1186/s12885-016-2124-5
Tarpgaard, L S, Qvortrup, C, Nygård, S B, Nielsen, S L, Andersen, D R, Jensen, N F, Stenvang, J, Detlefsen, S, Brünner, N & Pfeiffer, P 2016, ' A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification ', B M C Cancer, vol. 16, 91 . https://doi.org/10.1186/s12885-016-2124-5
UNLABELLED: ᅟ: The overall purpose of this study is to provide proof of concept for introducing the anthracycline epirubicin as an effective, biomarker-guided treatment for metastatic colorectal cancer (mCRC) patients who are refractory to treatmen